Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth M Van Cott

Showing results (51-60 of 109) with videos related to

Pageof 11
Sort By:
American Journal of Hematology|February 28, 2012
Approaches to investigating common bleeding disorders: an evaluation of North American coagulation laboratory practicesCatherine P M Hayward, Karen A Moffat, Elizabeth Plumhoff, et al.
Critical Care (London, England)|November 18, 2006
Outcome of postoperative critically ill patients with heparin-induced thrombocytopenia: an observational retrospective case-control studyElise M Gettings, Kathryn A Brush, Elizabeth M Van Cott, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|January 23, 2018
The effects of transport temperature and time on routine and specialized coagulation assaysYeowon A Kim, Kent B Lewandrowski, Fils-Amie Lucien, et al.
American Journal of Hematology|August 12, 2020
Evaluation of the prothrombin fragment 1.2 in patients with coronavirus disease 2019 (COVID-19)Hanny Al-Samkari, Fei Song, Elizabeth M Van Cott, et al.
American Journal of Clinical Pathology|January 19, 2006
Cold-dependent loss of factor VIII von Willebrand factor activities in citrated whole blood is reversed by rewarmingMajed A Refaai, Michael Lukoszyk, James Hughes, et al.
International Journal of Laboratory Hematology|June 17, 2020
Patient advocacy and its importance to laboratory medicine practiceCatherine P M Hayward, Tracy I George, Elizabeth M Van Cott, et al.
Stroke|October 15, 2011
Recombinant activated coagulation factor VII and prothrombin complex concentrates are equally effective in reducing hematoma volume in experimental warfarin-associated intracerebral hemorrhageFrieder Schlunk, Elizabeth M Van Cott, Kazuhide Hayakawa, et al.
American Journal of Clinical Pathology|January 6, 2006
Effects of marathon running on platelet activation markers : direct evidence for in vivo platelet activationAlexander Kratz, Malissa J Wood, Arthur J Siegel, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 25, 2020
Coagulation Status and Venous Thromboembolism Risk in African Americans: A Potential Risk Factor in COVID-19Galit H Frydman, Edward W Boyer, Rosalynn M Nazarian, et al.
Seminars in Thrombosis and Hemostasis|February 6, 2014
Proficiency testing results for heparin-induced thrombocytopenia in north americaKristi J Smock, Marlies R Ledford-Kraemer, Piet Meijer, et al.
Pageof 11

Showing results (51-60 of 109) with videos related to

Sort By:
Pageof 11
American Journal of Hematology|February 28, 2012
Approaches to investigating common bleeding disorders: an evaluation of North American coagulation laboratory practicesCatherine P M Hayward, Karen A Moffat, Elizabeth Plumhoff, et al.
Critical Care (London, England)|November 18, 2006
Outcome of postoperative critically ill patients with heparin-induced thrombocytopenia: an observational retrospective case-control studyElise M Gettings, Kathryn A Brush, Elizabeth M Van Cott, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|January 23, 2018
The effects of transport temperature and time on routine and specialized coagulation assaysYeowon A Kim, Kent B Lewandrowski, Fils-Amie Lucien, et al.
American Journal of Hematology|August 12, 2020
Evaluation of the prothrombin fragment 1.2 in patients with coronavirus disease 2019 (COVID-19)Hanny Al-Samkari, Fei Song, Elizabeth M Van Cott, et al.
American Journal of Clinical Pathology|January 19, 2006
Cold-dependent loss of factor VIII von Willebrand factor activities in citrated whole blood is reversed by rewarmingMajed A Refaai, Michael Lukoszyk, James Hughes, et al.
International Journal of Laboratory Hematology|June 17, 2020
Patient advocacy and its importance to laboratory medicine practiceCatherine P M Hayward, Tracy I George, Elizabeth M Van Cott, et al.
Stroke|October 15, 2011
Recombinant activated coagulation factor VII and prothrombin complex concentrates are equally effective in reducing hematoma volume in experimental warfarin-associated intracerebral hemorrhageFrieder Schlunk, Elizabeth M Van Cott, Kazuhide Hayakawa, et al.
American Journal of Clinical Pathology|January 6, 2006
Effects of marathon running on platelet activation markers : direct evidence for in vivo platelet activationAlexander Kratz, Malissa J Wood, Arthur J Siegel, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 25, 2020
Coagulation Status and Venous Thromboembolism Risk in African Americans: A Potential Risk Factor in COVID-19Galit H Frydman, Edward W Boyer, Rosalynn M Nazarian, et al.
Seminars in Thrombosis and Hemostasis|February 6, 2014
Proficiency testing results for heparin-induced thrombocytopenia in north americaKristi J Smock, Marlies R Ledford-Kraemer, Piet Meijer, et al.
Pageof 11